When AI Takes Over CAD Pre-Screening
Originally published on explorishealth.com
An article exploring how artificial intelligence is being used for the pre-screening of coronary heart disease.
In more than half of all heart attacks, there were no prior symptoms. Yet we almost exclusively screen for heart disease only when someone has symptoms. The result: Germany leads the world in cardiac catheterizations—and at the same time ranks last in Europe in terms of life expectancy. AI can change that. The Cardio Explorer® analyzes simple lab values and calculates an individual’s risk of CHD—with over 95% accuracy, effortlessly, and fully automated within the hospital information system. Many thanks to Prof. Andrew Remppis for his clear perspective on a long-overdue topic.
Are you interested in how Cardio Explorer® applies to your coronary pathway? Our team would be happy to walk you through the platform and the evidence behind it.
